BE708557A - - Google Patents

Info

Publication number
BE708557A
BE708557A BE708557DA BE708557A BE 708557 A BE708557 A BE 708557A BE 708557D A BE708557D A BE 708557DA BE 708557 A BE708557 A BE 708557A
Authority
BE
Belgium
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE708557A publication Critical patent/BE708557A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • C07D265/32—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings with oxygen atoms directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
BE708557D 1966-12-28 1967-12-27 BE708557A (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB57963/66A GB1138405A (en) 1966-12-28 1966-12-28 Morpholine derivatives
GB5796367 1966-12-28

Publications (1)

Publication Number Publication Date
BE708557A true BE708557A (de) 1968-06-27

Family

ID=26267707

Family Applications (1)

Application Number Title Priority Date Filing Date
BE708557D BE708557A (de) 1966-12-28 1967-12-27

Country Status (7)

Country Link
US (1) US3714161A (de)
BE (1) BE708557A (de)
CH (1) CH504452A (de)
DE (1) DE1695295C2 (de)
FR (2) FR1571341A (de)
GB (1) GB1138405A (de)
NL (1) NL157303B (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4317141A1 (de) 2022-08-04 2024-02-07 Curia Spain S.A.U. Verfahren und zwischenprodukte zum herstellen von vioxazin und anderen 2-substituierten morpholinderivaten

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3959273A (en) * 1966-12-28 1976-05-25 Imperial Chemical Industries Limited Morpholine derivatives
US3857839A (en) * 1969-06-20 1974-12-31 Ici Ltd For cyclising 1-aryloxy-3 beta-substituted ethylamino-2-propanols
BE759013R (fr) * 1969-11-17 1971-05-17 Ici Ltd Derives de la
BE758766A (fr) * 1969-11-17 1971-05-10 Ici Ltd Nouveaux derives de la morpholine et de la
US3806595A (en) * 1971-08-09 1974-04-23 Ici Ltd Method of producing anorexia
GB1382526A (en) * 1972-08-11 1975-02-05 Ici Ltd Morpholine derivatives
US4033951A (en) * 1973-12-13 1977-07-05 Imperial Chemical Industries Limited Morpholine derivative of a 1,4-benzothiazin-3-one
US4079135A (en) * 1973-12-13 1978-03-14 Imperial Chemical Industries Limited Morpholine derivatives as antidepressants
CA1064927A (en) * 1975-01-29 1979-10-23 Yuji Kawashima Process of producing 2-(indenyloxymethyl) morpholine derivatives
US4109088A (en) * 1975-01-29 1978-08-22 Yamanouchi Pharmaceutical Co., Ltd. 2-(indenyloxymethyl) morpholine derivatives
US4005084A (en) * 1975-07-10 1977-01-25 Yoshitomi Pharmaceutical Industries, Ltd. Thienylmethyl phenoxy morpholine compounds
DE2530860C2 (de) * 1975-07-10 1987-01-15 Yoshitomi Pharmaceutical Industries, Ltd., Osaka 2-[2-(2-Thenyl)-phenoxymethyl]-morpholin-Derivate
IL56369A (en) * 1978-01-20 1984-05-31 Erba Farmitalia Alpha-phenoxybenzyl propanolamine derivatives,their preparation and pharmaceutical compositions comprising them
US4241059A (en) * 1979-12-17 1980-12-23 E. R. Squibb & Sons, Inc. 6-[(Aryloxy)methyl]-2-morpholinemethanol derivatives and use thereof
FR2534915B1 (fr) * 1982-10-26 1985-10-25 Lafon Labor Nouveaux derives de 2-(phenoxymethyl)-morpholine, utilisation en therapeutique et procede de preparation
FR2575158B1 (fr) * 1984-12-20 1987-10-02 Pf Medicament Arylalcoyloxymethyl-2 morpholines, leur preparation et leur application en tant que medicaments utiles dans le traitement des troubles du systeme nerveux central
FR2612926B1 (fr) * 1987-03-24 1989-06-09 Adir Nouveaux derives de la morpholine, leur procede de preparation et les compositions pharmaceutiques les renfermant
EP0629190A1 (de) * 1992-01-28 1994-12-21 Smithkline Beecham Plc Verbindungen als calcium kanal antagoniste
CA2155183A1 (en) * 1993-02-10 1994-08-18 Mitsuo Fujii Morpholine derivative
AU9087301A (en) 2000-09-11 2002-03-26 Sepracor Inc Ligands for monoamine receptors and transporters, and methods of use thereof
US7294637B2 (en) 2000-09-11 2007-11-13 Sepracor, Inc. Method of treating addiction or dependence using a ligand for a monamine receptor or transporter
AP2006003771A0 (en) * 2004-04-30 2006-10-31 Warner Lambert Co Substituted morpholine compounds for the treatmentof central nervous system disorders
GB0409744D0 (en) * 2004-04-30 2004-06-09 Pfizer Ltd Novel compounds
SI2076508T1 (sl) 2006-10-18 2011-04-29 Pfizer Prod Inc Spojine biaril eter sečnine
CA2735934C (en) 2008-09-05 2014-01-07 Supernus Pharmaceuticals, Inc. Method of treatment of attention deficit/hyperactivity disorder (adhd)
EP2558437B1 (de) 2010-04-12 2015-08-05 Supernus Pharmaceuticals, Inc. Verfahren zur herstellung von viloxazinsalzen und neue polymorphe daraus
WO2011146821A2 (en) 2010-05-21 2011-11-24 Research Triangle Institute 1 - phenylmorpholine derivatives as hydroxybupropion analogues for treating drug dependence
JP2013526583A (ja) 2010-05-21 2013-06-24 リサーチ・トライアングル・インスティチュート フェニルモルホリンおよびその類似体
MX356727B (es) 2012-02-08 2018-06-12 Supernus Pharmaceuticals Inc Formulaciones de liberacion modificada de viloxacina.
WO2025219523A1 (en) 2024-04-19 2025-10-23 Cambrex Profarmaco Milano S.R.L. "intermediates and processes for the preparation of viloxazine"

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH356451A (de) * 1957-04-05 1961-08-31 Geigy Ag J R Verfahren zur Herstellung von neuen Morpholinverbindungen

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4317141A1 (de) 2022-08-04 2024-02-07 Curia Spain S.A.U. Verfahren und zwischenprodukte zum herstellen von vioxazin und anderen 2-substituierten morpholinderivaten
WO2024028423A1 (en) 2022-08-04 2024-02-08 Curia Spain, S.A.U. Process and intermediates for the preparation of viloxazine and other 2-substituted morpholine derivatives

Also Published As

Publication number Publication date
GB1138405A (en) 1969-01-01
CH504452A (de) 1971-03-15
DE1695295A1 (de) 1975-03-20
NL157303B (nl) 1978-07-17
NL6717719A (de) 1968-07-01
FR1571341A (de) 1969-06-20
FR7557M (de) 1969-12-29
US3714161A (en) 1973-01-30
DE1695295C2 (de) 1984-01-05

Similar Documents

Publication Publication Date Title
FR1571341A (de)
BE694014A (de)
BE694155A (de)
BE694612A (de)
BE694367A (de)
BE694209A (de)
BE694163A (de)
BE694158A (de)
BE693915A (de)
BE693850A (de)
BE693687A (de)
BE693486A (de)
BE693464A (de)
BE693096A (de)
BE693023A (de)
BE692747A (de)
BE692196A (de)
BE691699A (de)
BE691471A (de)
BE691323A (de)
BE691275A (de)
BE690752A (de)
BE690140A (de)
BE689764A (de)
BE689210A (de)

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: IMPERIAL CHEMICAL INDUSTRIES LTD

Effective date: 19871227